September 2017 Default Cover Image
Rivaroxaban Shown to Cut Risk of Cardiovascular EventsRivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.
Balancing Act: Dealing with Stress in the PharmacyIt's no news that pharmacists are stressed, but how is it affecting job performance—and how do pharmacists cope?
PBMs Look to the FuturePBMs are evolving, but what will they be evolving into and will they be more transparent?
Neratinib for Early Stage Breast CancerNeratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy.
Pharmacists Can Help Reduce Repeat MIsNonadherence to treatment plans is a contributing factor in for many second myocardial infarctions.
Are You Keeping Your Patients' Digital Info Safe?Ransomware and cybersecurity threats expose patients to risks.
The Underappreciated Risks of Hospital IV CompoundingTechnology can help reduce error rates in IV compounding.
Limits on Opioid Prescriptions Gain PopularityOpioid limits are gaining popularity, but do they actually work?
Express Scripts’ New Formulary Favors Biosimilars, Cuts OpioidsCheck out the latest changes to the Express Scripts formulary
“Check Your Meds Day” Is ComingHow one day could help your patients manage their meds.
Clinical Challenge: Treating Nasal Congestion with Concomitant HypertensionIn Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.